Spinal and bulbar muscular atrophy | |
---|---|
Other names | Kennedy's disease (KD), spinobulbar muscular atrophy, bulbo-spinal atrophy, X-linked bulbospinal neuropathy (XBSN), X-linked spinal muscular atrophy type 1 (SMAX1), and many other names[1] |
This disorder is inherited via X-linked recessive manner | |
Specialty | Neurology |
Symptoms | Weakness of limb and bulbar muscles, tremor, fasciculations, muscle cramps, dysarthria and dysphagia |
Causes | Mutation in the AR gene |
Diagnostic method | Number of CAG repeats in the AR gene |
Treatment | Supportive Care |
Spinal and bulbar muscular atrophy (SBMA), popularly known as Kennedy's disease, is a rare, adult-onset, X-linked recessive lower motor neuron disease caused by trinucleotide CAG repeat expansions in exon 1 of the androgen receptor (AR) gene, which results in both loss of AR function and toxic gain of function.[2][3]
In men, the disease slowly progresses over decades with bulbar and lower motor neuron loss, muscle denervation, and direct skeletal muscle involvement.[4][5] The disease causes progressive muscle loss with weakness, fasciculations, and cramps. Weakness of the bulbar muscles follows causing difficulties in speech (dysarthria) and swallowing (dysphagia). Female carriers do not show symptoms. Although there is no cure, supportive intervention can improve mobility and reduce complications. The prevalence of SBMA has been estimated at 2.6:100,000 males.[6]
There is no known cure for SBMA.[7][8][9] Supportive care is focused on preventing disease complications and maintaining independence.
:4
was invoked but never defined (see the help page).pmid4233749
was invoked but never defined (see the help page).pmid16389310
was invoked but never defined (see the help page).:12
was invoked but never defined (see the help page).:052
was invoked but never defined (see the help page).